Search Results - "Loupatty, Ference J."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Enzymology of the branched-chain amino acid oxidation disorders: the valine pathway by Wanders, Ronald J. A., Duran, Marinus, Loupatty, Ference J.

    Published in Journal of inherited metabolic disease (01-01-2012)
    “…Valine is one of the three branched-chain amino acids which undergoes oxidation within mitochondria. In this paper, we describe the current state of knowledge…”
    Get full text
    Journal Article
  2. 2

    Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum by Janssen, Marcel J.W., Wielders, Jos P.M., Bekker, Corinne C., Boesten, Lianne S.M., Buijs, Madelon M., Heijboer, Annemieke C., van der Horst, Frans A.L., Loupatty, Ference J., van den Ouweland, Johannes M.W.

    Published in Steroids (01-11-2012)
    “…► Ten methods to measure serum 25-hydroxyvitamin D were compared with ID–LC–MS/MS. ► Significant bias exists between ID–LC–MS/MS and many, but not all, other…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Formulas for Calculating Calcium Values Underestimate Hypocalcemia in Hemodialysis Patients by van Holten, Thijs C, van der Horst, Frans A L, Huisman, Sebastiaan J, Loupatty, Ference J

    Published in Clinical chemistry (Baltimore, Md.) (01-11-2016)
    “…The Kidney Disease: Improving Global Outcomes (KDIGO)1 work group developed a clinical practice guideline on mineral and bone disorders and have advised…”
    Get full text
    Journal Article
  5. 5

    Can serum L-lactate, D-lactate, creatine kinase and I-FABP be used as diagnostic markers in critically ill patients suspected for bowel ischemia by van der Voort, Peter H J, Westra, Berit, Wester, Jos P J, Bosman, Rob J, van Stijn, Ilse, Haagen, Inez-Anne, Loupatty, Ference J, Rijkenberg, Saskia

    Published in BMC anesthesiology (02-12-2014)
    “…The prognostic value of biochemical tests in critically ill patients with multiple organ failure and suspected bowel ischemia is unknown. In a prospective…”
    Get full text
    Journal Article
  6. 6

    3-Methylglutaconic Aciduria Type I Is Caused by Mutations in AUH by IJlst, Lodewijk, Loupatty, Ference J., Ruiter, Jos P.N., Duran, Marinus, Lehnert, Willy, Wanders, Ronald J.A.

    Published in American journal of human genetics (01-12-2002)
    “…3-Methylglutaconic aciduria type I is an autosomal recessive disorder clinically characterized by various symptoms ranging from delayed speech development to…”
    Get full text
    Journal Article
  7. 7

    NMR spectroscopic studies on the late onset form of 3-methylglutaconic aciduria type I and other defects in leucine metabolism by Engelke, Udo F. H., Kremer, Berry, Kluijtmans, Leo A. J., van der Graaf, Marinette, Morava, Eva, Loupatty, Ference J., Wanders, Ronald J. A., Moskau, Detlef, Loss, Sandra, van den Bergh, Erik, Wevers, Ron A.

    Published in NMR in biomedicine (01-04-2006)
    “…A diagnosis of 3‐methylglutaconic aciduria type I (OMIM: 250950) based on elevated urinary excretion of 3‐methylglutaconic acid (3MGA), 3‐methylglutaric acid…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Clinical, biochemical, and molecular findings in three patients with 3-hydroxyisobutyric aciduria by Loupatty, Ference J., van der Steen, Annemarie, IJlst, Lodewijk, Ruiter, Jos P.N., Ofman, Rob, Baumgartner, Matthias R., Ballhausen, Diana, Yamaguchi, Seiji, Duran, Marinus, Wanders, Ronald J.A.

    Published in Molecular genetics and metabolism (01-03-2006)
    “…3-Hydroxyisobutyric aciduria is a rare entity and affected individuals display a range of clinical manifestations including dysmorphic features and…”
    Get full text
    Journal Article
  10. 10